International Journal of Radiation Oncology*Biology*Physics

Oncology & Cancer

Stereotactic radiation feasible for oligometastatic cancer

(HealthDay)—Stereotactic ablative radiation therapy (SABR) for recurrent oligometastatic cancer is a feasible and tolerable treatment option, according to a phase 2 study published in the January issue of the International ...

page 2 from 9